ArticleActa oncologica (Stockholm, Sweden)2025

Outcomes for patients with high-risk ER-positive, HER2-negative early-stage breast cancer: a Danish real-world study.

Ida Christine Jacobsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.